期刊文献+

基于他克林的乙酰胆碱酯酶抑制剂的3D-QSAR研究及虚拟筛选 被引量:9

Virtual screening and 3D-QSAR study based on acetylcholinesterase inhibitors of tacrine
下载PDF
导出
摘要 本文通过对58个他克林派生物乙酰胆碱酯酶抑制剂分子进行建模分析,研究其结构与活性的关系,并通过虚拟筛选方法获得一系列潜在AChE抑制剂双位点分子。首先将一系列他克林二联体化合物与AChE晶体结构对接,获得化合物的活性构象,以此进行建模分析,建立结构与活性之间的三维定量构效关系。所得模型CoMFA、CoMSIA、TopomerCoMFA的交叉验证系数分别为0.510、0.702、0.571,非交叉验证系数为0.998、0.988、0.794,测试集r2pred为0.750、0.742、0.766,所得模型具有良好的预测性,由此可以为设计高活性的新分子提供理论基础。然后,使用Topomer search对ZINC数据库中的125909分子进行虚拟筛选,得到891个具有潜在AChE抑制活性的分子。最后,对这891个分子进行分子对接,观察分子与晶体结构的结合情况,筛选得到66个具有高选择性的双位点AChE抑制剂分子。 In this study,58 acetylcholinesterase(AChE)inhibitors were studied for the relationship between structure and activity.A series of potential dual binding AChE inhibitors were obtained by virtual screening.First,bioactive conformations were generated by docking a series of Tacrine Dimers Analogs with AChE crystal structure.3D quantitative structure activity relationship (3D-QSAR) models were developed for AChE inhibitors using modeling analysis.The cross-validated coefficient q 2 values of 3D-QASR(CoMFA, CoMSIA,and TopomerCoMFA ) methods were 0.510,0.702,and 0.571,the non-cross-validated r 2 values were 0.998,0.988, 0.794,r2pred were 0.826,0.776,0.766 and all these models have good predictability ,and provide theoretical basis for designing new high activity molecules.Then 125,909 molecules obtained from ZINC database were virtual screened by using Topomer search ,891 molecules with potential AChE inhibitory activity were obtained.Finally,the combination of 891 molecules and AChE crystal struc-ture were confirmed by using molecular docking ,66 molecules endowed with dual binding were obtained ,which have high selectivity of AChE inhibitory activity.
出处 《化学研究与应用》 CAS CSCD 北大核心 2014年第2期241-249,共9页 Chemical Research and Application
基金 北京市教委项目(KM201310028007)资助 北京市中青年骨干教师项目(PHR201108146)资助
关键词 阿尔茨海默病 乙酰胆碱酯酶抑制剂 QSAR 分子对接 虚拟筛选 Alzheimer's disease acetyt cholinesterase inhibitor QSAR docking virtual screening
  • 相关文献

参考文献32

  • 1Bi B,Lin H,Cheng Y. Promotion of b-amyloid pro-duction by C-reactive protein and its implications in the early pathogenesis of Alzheimer's disease[J].Neurochem-istry International,2012.257-266.
  • 2TumiattiV,Minarini A,Bolognesi ML. Tacrine deriv-atives and Alzheimers disease[J].{H}Current Medicinal Chemistry,2010,(17):1825-1838.
  • 3Scarpini E,Scheltens P,Feldman H. Treatment of Alzhei-mer′s disease:current status and new perspectives[J].{H}Lancet Neurology,2003,(09):539-547.
  • 4Xie Q,Wang H,Xia Z. Bis-(-)-nor-meptazinols as novel nanomolar cholinesterase inhibitors with high inhibi-tory potency on amyloid-βaggregation[J].Journal of Me-dicinal Chemistry,2008,(07):2027-2036.
  • 5Munoz-Torrero D. Acetylcholinesterase inhibitors as dis-ease-modifying therapies for Alzheimer's disease[J].Cur-rent Medicinal Chemistry,2008,(24):2433-2455.
  • 6Raves ML,Harel M,Pang YP. Structure of acetylcho-linesterasecomplexed with the nootropic alkaloid,(-)-hu-perzineA[J].{H}Natural Structural Biology,1997,(01):57-63.
  • 7Samadi A,Revenga M,Pérez C. pharmacological as-sessment,and molecular modeling of 6-chloro-pyridonepez-ils:new dual AChE inhibitors as potential drugs for the treatment of Alzheimer's disease[J].{H}European Journal of Medicinal Chemistry,2013.64-74.
  • 8Romero A,Cacabelos R,Oset-Gasque MJ. Novel tac-rine-related drugs as potential candidates for the treatment of Alzheimer's disease[J].Bioorganic&Medicinal Chemis-try Letters,2013.1916-1922.
  • 9Ramdane S. Donepezil in the treatment of Alzheimer's dis-ease:results from a routine clinical practice setting[J].Alzheimer's&Dementia,2012,(04):716-717.
  • 10Fang L,Appenroth D,Decker M. NO-Donating tac-rinehHybrid compounds improve Scopolamine-Induced cognition impairment and show less hepatotoxicity[J].{H}Journal of Medicinal Chemistry,2008,(24):7666-7669.

二级参考文献11

共引文献3

同被引文献84

  • 1姚婵,来茂德.上皮间质转化(EMT)及其分子机制[J].国际遗传学杂志,2006,29(4):290-294. 被引量:25
  • 2李占潮,吕庆章.HIV-1逆转录酶抑制剂2-氨基6-苯磺酰基苄腈及其类似物活性OSAR研究[J].化学研究与应用,2006,18(10):1152-1156. 被引量:1
  • 3陆阳,刘俊义.有机化学[M].北京:人民卫生出版社2013:487.
  • 4Liew K, Yong P V, Lim Y M, et al. 2-Methoxy-1 ,4-Naphthoquinone ( MNQ) suppresses the invasion and migration of a human metastatic breast cancer cell line (MDA-MB- 231 )[J]. Toxicolln Vitro,2014 ,28(3) :335-339.
  • 5Song G Y ,Kim Y, Zheng X G, et al. Naphthazarin derivatives ( IV ) : synthesis, inhibition of DNA topoisomerase I and cytotoxicity of 2-or 6-acyl-5, 8-dimethoxy-l ,4-naphthoquinones[J]. EurJ Med Chem,2000 ,35 (3) :291-298.
  • 6Song G Y ,Kim Y, You YJ ,et al. Naphthazarin derivatives ( VI) : synthesis, inhibitory effect on DNA topoisomerase-I and antiproliferative activity of 2-or 6-( l-oxyiminoalkyl)- 5, 8-dimethoxy-l , 4-naphthoquinones[J]. Arch Pharm (Weinheim) ,2000,333(4) :87-92.
  • 7Wang W , Dai M, Zhu C, et al. Synthesis and biological activity of novel shikonin analogues[J]. Bioorg Med Chem Lett ,2009 ,19( 3) :735-737.
  • 8Ordoudi SA, Tsermentseli S K, Nenadis N, et al. Structure-radical scavenging activity relationship of alkannin/ shikonin derivatives[J]. Food Chem,2011 ,124 ( 1 ) : 171- 176.
  • 9Ahn B Z, Baik K U, Kweon G R, et al. Acylshikonin analogues: synthesis and inhibition of DNA topoisomerase-I[J].J Med Chem,1995,38(6) :1044-1047.
  • 10Zhou W, Peng Y, Li S-S. Semi-synthesis and anti-tumor activity of 5, 8-0-dimethyl acylshikonin derivatives[J] . EurJ Med Chem,2010,45(l2) :6005-6011.

引证文献9

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部